Why you've plateaued on tirzepatide — and what can change

What is your body actually doing when the scales stop moving?

The plateau is not a malfunction. When body weight drops, the body defends itself: basal metabolic rate falls, hunger hormones shift, and energy efficiency rises. This is sometimes called adaptive thermogenesis, and it happens with every method of weight loss, not just GLP-1 or dual-agonist treatment. What changes with tirzepatide is the degree to which appetite suppression offsets that adaptation, but the adaptation still occurs.

Tirzepatide activates both the GIP and GLP-1 receptors, which is why it is the only dual-agonist weight-loss medicine licensed in the UK. That dual action slows gastric emptying and increases satiety signals, but neither mechanism overrides the body's long-term energy balance completely. After an initial period of faster loss (often the first eight to twelve weeks) the rate of change typically slows. The NHS's tirzepatide information page describes this as an expected part of how the medicine works, not a reason to stop.

It is also worth separating a true plateau from normal week-to-week fluctuation. Fluid retention, menstrual cycle, salt intake and sleep can all move the scales by one to three kilograms without any change in fat mass. A plateau is more meaningfully defined as four or more weeks of no net downward movement, and even then, body composition may still be improving if you are building or preserving muscle.

Does raising the dose break a tirzepatide plateau?

Often, yes. The licensed titration schedule for tirzepatide runs from 2.5mg through to 15mg in six steps, with four weeks at each level before a prescriber considers an increase. The SURMOUNT-1 trial, published in the New England Journal of Medicine, found that average weight reduction at 15mg was around 20 to 21% over 72 weeks, substantially above the results at lower maintenance doses. Participants who reached higher doses consistently showed greater overall loss, which tells us that plateaus encountered mid-titration often do resolve once the next dose step is reached.

That said, dose increases are a prescriber's decision, not something to self-manage. Your prescriber will look at how well you tolerated the current dose, your weight trajectory, and any symptoms before recommending a step up. If you are on a private tirzepatide prescription through a service like ours, that clinical review happens before every repeat, which is exactly the right moment to raise a plateau with your prescriber.

One point that surprises some people: the 5mg dose is the first therapeutic maintenance dose, while 2.5mg is a tolerability phase, its job is settling your system rather than driving significant weight loss. A plateau at 2.5mg is therefore almost expected and says nothing about how you will respond at higher doses. How quickly tirzepatide takes effect varies considerably by dose level.

What lifestyle factors interact with a plateau, and which ones actually matter?

Tirzepatide works best alongside a reduced-calorie diet and increased physical activity, and this is built into its licence. But the interaction during a plateau is more specific than the general advice suggests.

Protein adequacy is probably the most underappreciated factor. When appetite is significantly reduced, total calories fall quickly, but if protein falls proportionally, the body draws more energy from lean mass. That slows metabolism further and makes the plateau harder to break. Aiming for adequate protein at each meal, even when not feeling hungry, helps preserve muscle and keeps metabolic rate higher. Your prescriber or a dietitian can suggest appropriate targets; a general figure is not something to give here.

Strength-based activity matters for the same reason. Cardiovascular exercise burns calories during the session; resistance training raises the baseline metabolic rate over time. For people on tirzepatide who have hit a plateau, adding even two sessions of resistance work per week can shift the dynamic, and it supports long-term weight maintenance too.

Sleep is genuinely relevant, not just wellness background noise. Short or poor-quality sleep raises ghrelin (a hunger hormone) and lowers leptin, which partially offsets tirzepatide's appetite effects. Stress follows the same logic via cortisol. Neither of these is something to fix overnight, but they explain why a plateau sometimes resolves once life circumstances improve without any change to the prescription.

For a broader look at what to expect from treatment over time, our guide to the Mounjaro plateau covers the full timeline in more detail. And if you are weighing up the cost context of staying on treatment through a slower phase, the tirzepatide cost guide sets out what private treatment typically involves.

When should you speak to your prescriber rather than wait it out?

Most plateaus are self-limiting with patience and the adjustments above. But some warrant a proper clinical conversation sooner. NICE's recommendation for tirzepatide (TA1026) includes a review point: if weight loss is less than 5% after six months at the highest tolerated dose, the clinical case for continuing is reassessed. This does not mean treatment automatically stops, but it does mean an honest conversation with your prescriber is appropriate rather than continuing on the same trajectory indefinitely.

Other reasons to contact your prescriber rather than waiting: if you are losing weight faster than expected and feel unwell, if side effects have worsened at the current dose and you are unsure whether to titrate, or if you have developed a new health condition that may affect suitability. If you find yourself plateaued on Mounjaro and wondering whether your dose, diet, or activity levels are the cause, a prescriber who knows your full picture is better placed to advise than any general guidance. Our tirzepatide plateau guide also walks through the most common reasons progress stalls and what the evidence says about getting things moving again.

If you are not yet on treatment and researching what to expect, or if your current service has not offered the kind of clinical review that addresses these questions, a free consultation with one of our GPhC-registered prescribers is the place to start. A real clinician reads every response on the day it is submitted, not software, not a queue. Once approved, your medication is dispatched the same day if you order before noon, and arrives via DPD the next working day in plain, unmarked packaging. Straightforward, and clinically sound. Start your free consultation.